COVID-19 and Genitourinary Cancers

The effect of COVID-19 on prostate cancer testing in Australia. June 23, 2022

Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: A German survey on prostate cancer diagnosis and treatment. June 15, 2022

COVID-19 and financial toxicity in patients with renal cell carcinoma. April 23, 2022

Trends of Cancer Screenings, Diagnoses, and Mortalities During the COVID-19 Pandemic: Implications and Future Recommendations. April 19, 2022

Impact of the COVID-19 outbreak on prostate cancer care in the Netherlands. April 18, 2022

Black Patients with Cancer Fare Worse with COVID-19, Study Shows March 29, 2022

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer. March 29, 2022

Moffitt Study Finds Cancer Patients Do Benefit From COVID-19 Vaccination March 11, 2022

Geriatric risk factors for serious COVID-19 outcomes among older adults with cancer: a cohort study from the COVID-19 and Cancer Consortium. February 22, 2022

AACR Releases Report Outlining Impact of COVID-19 Pandemic on Cancer Research and Patient Care February 9, 2022

Incident Cancer Detection During the COVID-19 Pandemic. February 4, 2022

Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancer. February 4, 2022

Symptom burden profiles in men with advanced prostate cancer undergoing androgen deprivation therapy. February 4, 2022

Impact of the Covid-19 pandemic on the diagnosis and treatment of men with prostate cancer. January 27, 2022

Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months January 7, 2022

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer. December 27, 2021

Cancer case trends following the onset of the COVID-19 pandemic: A community-based observational study with extended follow-up. December 23, 2021

COVID-19 Infection, More Likely than Vaccines to Cause Rare Cardiovascular Complications December 14, 2021

Exploring the Diversity and Predictors of Histopathological Findings Across the European Association of Urology Guidelines Office Rapid Reaction Group Priority Groups for Patients with Renal Tumors: Implications for Individualized Prioritization of Renal November 16, 2021

Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise? November 9, 2021

Page 1 of 17

email news signup